ArthroCare (ARTC) Reports In-Line Q2 EPS of 34c
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Price: $9.97 --0%
Financial Fact:
Investigation and restatement related costs: 5.19M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Investigation and restatement related costs: 5.19M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
ArthroCare (NASDAQ: ARTC) reported Q2 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $91.3 million versus the consensus estimate of $92.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
- Enhanced Group Inc. (ENHA) Reports Q2 Loss of $0.53
- Shotspotter (SSTI) Misses Q2 EPS by 19c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
